Neuropathic in the Acute Post Operative Phase

September 28, 2011 updated by: Rigshospitalet, Denmark

Identification of Neuropathic Pain in the Acute Post Operative Phase Following Thoracotomy

Investigation of thermal thresholds and sensory mapping to thermal stimuli

Study Overview

Status

Terminated

Conditions

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Denmark
      • Copenhagen, Denmark, 2100
        • Section for Surgical Pathophysiology 4074
      • Copenhagen, Denmark, 2100
        • Rigshospitalet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Lung cancer patients undergoing thoracotomy

Description

Inclusion Criteria:

  • age > 18 years old

Exclusion Criteria:

  • do not under stand Danish
  • cognitive reduction
  • previous thoracic surgery
  • Pregnant or nursing
  • inability to cooperate to pain scoring

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
lung cancer surgery
Patients undergoing thoracotomy for lung cancer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain
Time Frame: 14 days
pain intensity
14 days
quantitative sensory testing (QST)
Time Frame: 14 days
thermal thresholds assesses via QST
14 days
Neuropathic pain
Time Frame: 14 days
is the pain considered neuropathic
14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Rigshospitalet, Denmark

Collaborators

Innovative Medicines Initiative
Section for Surgical Pathophysiology
Section of Acute Pain Management and Palliative Medicine
Multidisciplinary Pain Centre

Investigators

  • Principal Investigator: Kim Wildgaard, MD, Section for Surgical Pathophysiology
  • Study Chair: Henrik Kehlet, MD, Section for Surgical Pathophysiology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

September 1, 2011

Study Completion (Actual)

September 1, 2011

Study Registration Dates

First Submitted

February 22, 2011

First Submitted That Met QC Criteria

February 22, 2011

First Posted (Estimate)

February 23, 2011

Study Record Updates

Last Update Posted (Estimate)

September 29, 2011

Last Update Submitted That Met QC Criteria

September 28, 2011

Last Verified

September 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • H4-2010-118#1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe